Sign in

CIK 0001425205

  • Accelerated filer

IOVANCE BIOTHERAPEUTICS, INC.

Sign in to watch
Ticker
IOVA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
753254381
Phone
+1 650-260-7120
Business address
825 INDUSTRIAL ROAD, 4TH FLOOR, SAN CARLOS, CA, 94070
Former names
Lion Biotechnologies, Inc., Genesis Biopharma, Inc, FREIGHT MANAGEMENT CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 99 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-06-10 Countouriotis Athena Director Grant or award · Deferred Restricted Stock Unit +51,204 51,204
2022-06-10 MCPEAK MERRILL A Director Grant or award · Deferred Restricted Stock Unit +51,204 51,204
2022-06-10 Maynard Ryan D Director Grant or award · Deferred Restricted Stock Unit +51,204 51,204
2022-06-10 WEISER MICHAEL Director Grant or award · Deferred Restricted Stock Unit +51,204 51,204
2022-06-10 Dukes Iain D. Director Grant or award · Deferred Restricted Stock Unit +102,409 102,409
2022-06-10 DIXON WENDY L Director Grant or award · Deferred Restricted Stock Unit +51,204 51,204
2022-06-01 Vogt Frederick G Interim CEO & General Counsel Purchase +1,000 $6.44 $6K 1,000
2022-06-01 Rothbaum Wayne P. Director Purchase +500,000 $6.43 $3.2M 8,067,333
2022-05-31 MCPEAK MERRILL A Director Purchase +10,000 $6.84 $68K 20,150
2022-05-31 MCPEAK MERRILL A Director Purchase +10,000 $6.80 $68K 218,633
2022-05-31 Maynard Ryan D Director Purchase +7,500 $6.75 $51K 7,500
2022-05-31 WEISER MICHAEL Director Purchase +2,187 $6.79 $15K 104,819
2022-05-31 WEISER MICHAEL Director Purchase +7,813 $6.80 $53K 112,632
2022-05-31 Rothbaum Wayne P. Director Purchase +500,000 $6.77 $3.4M 7,567,333
2022-01-14 Vogt Frederick G Interim CEO & General Counsel Grant or award · Restricted Stock Units +250,000 250,000
2022-01-14 GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer Grant or award · Restricted Stock Units +33,750 33,750
2022-01-14 GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer Grant or award · Stock Option (right to buy) +67,500 67,500
2022-01-14 BILINSKY IGOR Chief Operating Officer Grant or award · Restricted Stock Units +33,750 33,750
2022-01-14 BILINSKY IGOR Chief Operating Officer Grant or award · Stock Option (right to buy) +67,500 67,500
2022-01-14 Bellemin Jean-Marc Chief Financial Officer Grant or award · Stock Option (right to buy) +135,000 135,000

Page 21 of 23 · 446 trades